Vitamin D deficiency among Polish patients with angiographically confirmed coronary heart disease

Ewelina A Dziedzic1, Jakub S Gąsior2, Tomasz Saniewski3

  • 1Faculty of Medicine, the Lazarski University of Warsaw, Poland.

Insights

Ninety-four percent of Polish patients with coronary artery disease have vitamin D deficiency, with 22% experiencing severe deficiency. These findings highlight the need for strategies to address vitamin D levels in this population.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Limited epidemiological data exists on serum vitamin D levels in Polish patients diagnosed with coronary artery disease (CAD).
  • Vitamin D plays a role in cardiovascular health, and CAD remains a leading cause of death globally.
  • Addressing vitamin D deficiency is crucial for managing cardiovascular risk.

Purpose of the Study:

  • To prospectively evaluate vitamin D concentrations in Polish patients undergoing coronary angiography for suspected CAD.
  • To determine the prevalence of vitamin D deficiency and its severity in this patient cohort.

Main Methods:

  • A prospective study included 1,043 patients (374 women, 669 men; mean age 66.9 years) undergoing coronary angiography between 2013-2017.
  • Plasma 25(OH)D concentrations were measured using electrochemiluminescence.
  • Patients were categorized based on vitamin D levels: optimal (≥30 ng/ml), mild deficiency (20-29.9 ng/ml), moderate deficiency (10-19.9 ng/ml), and severe deficiency (<10 ng/ml).

Main Results:

  • The median 25(OH)D concentration was 15.2 ng/ml.
  • Vitamin D deficiency was prevalent in 94% of the study population.
  • Optimal vitamin D levels were observed in only 6% of patients.
  • Severe deficiency (<10 ng/ml) affected 22% of patients, while moderate and mild deficiencies were found in 50% and 22%, respectively.

Conclusions:

  • A high prevalence of vitamin D deficiency (94%) exists among Polish patients with angiographically confirmed coronary artery disease.
  • A significant proportion (22%) exhibit severe vitamin D deficiency.
  • Prophylactic and therapeutic interventions targeting vitamin D deficiency are recommended for this high-risk population in Poland.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
82
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
73
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
406
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
513
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
48
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
128